Notice Number: NOT-AG-18-058
Key Dates
Release Date: January 4, 2019
Issued by
National Institute on Aging (NIA)
Purpose
The purpose of this Notice is to amend the application types allowed, award budget, and award project period for RFA-AG-19-025 "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)".
Part 2, Section II, Award Information
Application Types Allowed
Currently reads:
New (Phase I, Fast-Track)
New (Phase II)
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
Modified to read:New (Phase I, Fast-Track)
New (Phase II)
New (Direct Phase II)
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
Award Budget
Currently reads:
Budgets up to $225,000 total costs per year for Phase I and up to $750,000 total costs per year for Phase II may be requested with appropriate justification.
Modified to read:
Budgets up to $300,000 total costs for Phase I and up to $1,000,000 total costs per year for Phase II may be requested with appropriate justification.
Award Project Period
Currently reads:
According to statutory guidelines, award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.
Modified to read:
According to statutory guidelines, award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Todd Haim, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-480-7867
Email: todd.haim@nih.gov